A sharp decline in Korean memory-chip giant SK Hynix has triggered a broader sell-off across the technology sector, fueling investor fears that the massive capital requirements of the artificial intelligence boom may be cannibalizing other markets and threatening to drive up consumer electronics prices through persistent inflation.
Steve Hoerter has ascended to the roles of chairman and chief executive at MBX Biosciences, taking the helm from Kent Hawryluk effective immediately. The leadership transition arrives as the clinical-stage biopharmaceutical firm prepares for a critical second half of 2026, marked by key trials and data readouts.
Alabama-based hedge fund Forager Capital Management has seen its latest attempt to take over Repay Holdings Corporation fall flat, as the fintech firm’s board unanimously rejected an unsolicited cash offer of $5.25 per share, labeling the proposal a significant undervaluation of the company’s market position.
A coalition of 12 states led by California has moved to block Paramount’s $81 billion acquisition of Warner Bros. Discovery, casting a shadow over the media landscape while broader communications stocks retreat amid investor anxiety regarding the impact of rising oil prices on consumer discretionary spending.
A $12 million penalty marks the largest fine ever issued for violating pre-merger filing requirements under the Hart-Scott-Rodino Act. Federal regulators allege that Edwards Lifesciences and Genesis MedTech deliberately structured a recent acquisition to bypass antitrust scrutiny and avoid mandatory waiting periods that could have stalled their market strategy.
SC II Acquisition has abruptly terminated its pursuit of an unnamed payments technology firm, effectively voiding a non-binding letter of intent that would have seen the firm absorb all outstanding equity. The company offered no explanation for the collapse of the deal, which ceases activity immediately.
Investors are pivoting toward defensive utility stocks as surging oil prices rattle broader market sentiment. While the sector broadly benefits from this flight to safety, the trend remains uneven, with specific regional pressures dragging down individual players like AGL Energy amid a persistent glut in the Australian power market.
Patients battling early-stage Alzheimer’s disease now have a path toward home-based care after the FDA approved a new autoinjector for Leqembi. This regulatory green light allows Eisai and Biogen to move beyond intravenous infusions, offering a more flexible delivery method for those managing mild cognitive impairment or early dementia.
A century of construction expertise changes hands as White Cap, a specialty supply firm, moves to acquire Gierke Robinson. The deal adds four Iowa locations to White Cap’s regional network, marking a strategic push to consolidate its service capabilities and footprint across the competitive Midwestern construction market.
A consortium led by private-equity giant Warburg Pincus has finalized an agreement to acquire a controlling interest in Pantherx Rare, a specialty pharmacy dedicated to orphan diseases. While the financial specifics remain undisclosed, reports suggest the transaction values the company at more than $7 billion including debt.
The board of directors at Lulu's Fashion Lounge Holdings has established a special committee tasked with evaluating strategic alternatives to maximize shareholder value. This move signals a potential pivot for the online retailer, which is currently weighing a possible sale or merger against its existing standalone business plan.
Five of Western Canada’s largest oil sands producers have formalized a landmark agreement with federal and Alberta officials, linking the future of carbon capture infrastructure to the approval of a massive new crude pipeline. The deal clears a critical path for increasing exports while meeting stringent emissions targets.
German shipping giant Hapag-Lloyd has revised its annual earnings guidance upward, projecting EBITDA between $2.7 billion and $3.7 billion. The upgrade follows a surge in spot freight rates and sustained market demand, despite the carrier facing significant operational hurdles within the volatile geopolitical landscape of the Middle East.
Investors pushed First Advantage shares up 5.8% to $20.68 on Monday, anticipating the company’s official move into the S&P SmallCap 600 index. This latest rally extends the stock’s performance to a 42% gain so far this year, signaling strong market confidence ahead of Tuesday’s trading session.
Shares of Northern Oil and Gas surged 6.3% to $19.68 in Monday trading, defying a recent 28% three-month slump. The market reacted sharply after the company boosted its stock repurchase authorization to $243 million, signaling confidence despite broader volatility in the energy sector.
A $225 million injection from the U.S. Department of Commerce is set to accelerate Bosch’s $2 billion overhaul of its Roseville facility. The funding bolsters a broader strategy to shift silicon carbide semiconductor production onto American soil, marking a significant pivot in the company's domestic manufacturing footprint.
A sharp reversal in artificial intelligence stocks pushed the Nasdaq composite lower today, fueled by a record 15% plunge in SK Hynix shares. The downturn marks a cooling period for the year's primary market engine, as investors grow increasingly skeptical about the sustainability of the recent AI-driven rally.
President Trump’s decision to reimpose a blockade on Iranian shipping sent energy markets into a sharp rally Monday, shattering hopes for a quick resolution to escalating tensions in the Middle East. The move follows a series of direct military strikes and the closure of the critical Strait of Hormuz.
A 6.8% surge in Genius Sports shares on Monday signaled renewed investor confidence following the company’s role in a new three-way partnership. By bridging Polymarket’s prediction platform with Mexico's premier professional soccer league, the company aims to monetize its official data streams in a volatile market environment.
As major lenders prepare to report second-quarter results this week, the industry faces a paradox: solid current revenues are being overshadowed by investor anxiety regarding long-term sustainability. While economic indicators remain robust, the market is pivoting from short-term credit concerns toward the durability of net interest income growth.
Investors pushed Oncolytics Biotech shares up 16% to $1.03 on Monday morning following the company's announcement of a critical FDA meeting scheduled for August. The discussion will center on integrating a registrational component into the ongoing study targeting RAS-mutant, microsatellite-stable metastatic colorectal cancer.
A 27% surge in Braiin shares followed the company’s debut of ARIA, an agentic automation platform tailored for global real estate. Despite this intraday climb to $7, the stock remains down 52% year-to-date, marking a volatile period for the AI platform provider as it pivots toward specialized industry software.
Two oil-and-gas producers have signed on to utilize Enterprise Group’s mobile natural gas-to-electricity systems, marking a strategic expansion for the company across Western Canada. This shift toward localized power generation reflects a broader move by energy firms to electrify operations using cleaner, on-site fuel sources.
A single intravenous dose of VY1706 reduced tau protein levels by up to 75% in non-human primates over six months, according to new toxicology data. Following these results, Voyager Therapeutics intends to move its investigational gene therapy into human clinical trials for early-stage Alzheimer’s disease later this year.
With shares climbing 23% over the past year, Richemont prepares to reveal its fiscal first-quarter performance this Wednesday. Analysts project the Swiss luxury conglomerate will report sales reaching 5.89 billion euros, a notable rise from the 5.41 billion euros recorded during the same period in the previous fiscal year.
Gadi Levin has stepped into the role of chief financial officer at A2Z Cust2Mate Solutions, the company announced Monday. He takes the helm from Alan Rootenberg, who will maintain his presence on the board of directors for the Nasdaq-listed retail technology firm.
A potential strike at Air Canada has been averted after the carrier reached a four-year tentative agreement with the International Association of Machinists and Aerospace Workers. The deal covers roughly 11,000 employees across technical operations, airport services, cargo, and logistics, providing a framework for labor stability through March 2030.
The U.S. Food and Drug Administration has officially accepted Bristol Myers Squibb’s application for mezigdomide, a potential new treatment for relapsed or refractory multiple myeloma. The regulatory body set a target action date of May 13, 2027, marking a significant milestone for the Princeton-based pharmaceutical firm.
Shares of Q32 Bio rocketed 81% to $20.25 in premarket trading after the clinical-stage biotechnology firm reported that its experimental drug, bempikibart, delivered a significant reduction in hair loss for patients suffering from alopecia.
India’s merchandise trade deficit surged to $30.43 billion in June, a sharp departure from the $19.10 billion recorded during the same period last year. The widening gap, reported Monday by the commerce and industry ministry, reflects a cooling in both import and export activity as the nation navigates complex trade negotiations.
